Growth Metrics

Edwards Lifesciences (EW) Retained Earnings (2016 - 2026)

Edwards Lifesciences has reported Retained Earnings over the past 17 years, most recently at $14.2 billion for Q4 2025.

  • For Q4 2025, Retained Earnings rose 5924.34% year-over-year to $14.2 billion; the TTM value through Dec 2025 reached $14.2 billion, up 5924.34%, while the annual FY2025 figure was $14.2 billion, 5924.34% up from the prior year.
  • Retained Earnings for Q4 2025 was $14.2 billion at Edwards Lifesciences, up from -$250.4 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $14.2 billion in Q4 2025 and troughed at -$256.0 million in Q3 2022.
  • A 5-year average of $4.1 billion and a median of $2.6 billion in 2021 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: crashed 104.47% in 2022 and later surged 5924.34% in 2025.
  • Year by year, Retained Earnings stood at $6.1 billion in 2021, then crashed by 104.2% to -$254.9 million in 2022, then grew by 4.75% to -$242.8 million in 2023, then fell by 0.7% to -$244.5 million in 2024, then surged by 5924.34% to $14.2 billion in 2025.
  • Business Quant data shows Retained Earnings for EW at $14.2 billion in Q4 2025, -$250.4 million in Q3 2025, and $13.9 billion in Q2 2025.